 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Royalty Pharma plc (RPRX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-18 Purchase | 2020-06-22 5:31 pm | Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 3,000,000 | $28 | $84,000,000 | 46,015,328 (Indirect) | View |
| 2020-06-15 Purchase | 2020-06-22 9:47 pm | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 50,000 | $28 | $1,400,000 | 50,000 (Indirect) | View |
| 2020-06-15 Purchase | 2020-06-22 9:54 pm | Royalty Pharma plc | RPRX | Lloyd George W. VP | 14,200 | $28 | $397,600 | 11,200 (Indirect Direct) | View |
| 2020-06-15 Purchase | 2020-06-22 9:55 pm | Royalty Pharma plc | RPRX | FORD WILLIAM E Director | 1,500,000 | $28 | $42,000,000 | 1,500,000 (Indirect) | View |
| 2020-06-15 Purchase | 2020-06-22 9:55 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 20,000 | $28 | $560,000 | 10,000 (Indirect) | View |
| 2020-06-15 Purchase | 2020-06-23 9:13 pm | Royalty Pharma plc | RPRX | Hite Christopher VP | 70,000 | $28 | $1,960,000 | 70,000 (Direct) | View |
| 2020-06-15 Purchase | 2020-06-23 9:14 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 15,000 | $28 | $420,000 | 15,000 (Indirect Direct) | View |
| 2020-06-15 Purchase | 2020-06-23 9:21 pm | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 2,950 | $28 | $82,600 | 1,450 (Indirect Direct) | View |
| 2020-10-20 Sale | 2020-10-22 9:48 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 463,200 | $42 | $19,454,400 | 0 (Indirect Direct) | View |
| 2020-10-20 Sale(A) | 2020-10-23 7:11 pm | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 463,200 | $42 | $19,454,400 | 0 (Direct) | View |
| 2020-12-17 Sale | 2020-12-18 2:36 pm | Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 7,301,050 | $43.92 | $320,672,208 | 38,714,280 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-06-15 Option Award | 2020-06-17 9:49 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 35,715 | $0 | 35,715 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 9:49 pm | N/A N/A | Royalty Pharma plc | RPRX | DESOUZA ERROL B Director | 35,715 | $0 | 35,715 (Direct) | View |
| 2020-06-18 Conversion | 2020-06-22 5:31 pm | N/A N/A | Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 43,015,328 | $0 | 46,015,328 (Indirect) | View |
| 2020-06-18 Conversion | 2020-06-22 5:31 pm | N/A N/A | Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner | 4,637,046 | $0 | 46,015,328 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 9,077,140 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 3,477,520 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 23,390,000 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 22,926,170 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 978,514 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 349,784 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 907,714 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 347,752 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 2,339,999 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:47 pm | N/A N/A | Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Nogra Group SICAF SIF MGG Strategic Nogra Group SICAF SIF GG Strategic Director 10% Owner | 2,292,617 | $0 | 50,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 262,760 | $0 | 11,200 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 7,730 | $0 | 11,200 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 83,638 | $0 | 11,200 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 596,707 | $0 | 11,200 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 28,326 | $0 | 11,200 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 353,000 | $0 | 11,200 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 26,276 | $0 | 11,200 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | FORD WILLIAM E Director | 2,667,385 | $0 | 1,500,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | FORD WILLIAM E Director | 171,350 | $0 | 1,500,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | FORD WILLIAM E Director | 76,127 | $0 | 1,500,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 123,310 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 118,500 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 942,738 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 112,156 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 138,479 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 4,868,033 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 13,293 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 12,774 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 1,677,574 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 12,331 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO Chairman 10% Owner | 11,850 | $0 | 10,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 25,030 | $0 | 195 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 29,117 | $0 | 195 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 631,468 | $0 | 195 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 2,698 | $0 | 195 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 200,000 | $0 | 195 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 2,503 | $0 | 195 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:13 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher VP | 62,500 | $0 | 70,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-23 9:13 pm | N/A N/A | Royalty Pharma plc | RPRX | Hite Christopher VP | 116,100 | $0 | 70,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-23 9:14 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 238,001 | $0 | 15,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-23 9:14 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 435,267 | $0 | 15,000 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-23 9:14 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 253,889 | $0 | 15,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:14 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 494,485 | $0 | 15,000 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:14 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 119,982 | $0 | 15,000 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 23,270 | $0 | 1,450 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 10,755 | $0 | 1,450 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 406,491 | $0 | 1,450 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 2,508 | $0 | 1,450 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 305,000 | $0 | 1,450 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 48,000 | $0 | 1,450 (Indirect) | View |
| 2020-06-15 Conversion | 2020-06-23 9:21 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 2,327 | $0 | 1,450 (Indirect) | View |
| 2020-08-13 Option Award | 2020-08-17 8:40 pm | N/A N/A | Royalty Pharma plc | RPRX | LOVE TED W Director | 7,280 | $0 | 17,280 (Direct) | View |
| 2020-08-13 Option Award | 2020-08-17 8:42 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 7,280 | $0 | 7,280 (Direct) | View |
| 2020-06-18 Option Award | 2020-09-23 8:26 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 12,500 | $0 | 12,637 (Direct) | View |
| 2020-06-18 Option Award | 2020-09-23 8:26 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 137 | $48 | 12,637 (Direct) | View |
| 2020-06-15 Option Award | 2020-09-23 8:28 pm | N/A N/A | Royalty Pharma plc | RPRX | DESOUZA ERROL B Director | 8,929 | $0 | 53,915 (Direct) | View |
| 2020-06-15 Option Award | 2020-09-23 8:28 pm | N/A N/A | Royalty Pharma plc | RPRX | DESOUZA ERROL B Director | 53,915 | $0 | 53,915 (Indirect) | View |
| 2020-06-18 Option Award | 2020-09-23 8:29 pm | N/A N/A | Royalty Pharma plc | RPRX | Engelbert Catherine M. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2020-06-15 Option Award | 2020-09-23 8:30 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 8,929 | $0 | 15,594 (Direct) | View |
| 2020-06-15 Option Award | 2020-09-23 8:30 pm | N/A N/A | Royalty Pharma plc | RPRX | Norden Gregory Director | 15,594 | $0 | 15,594 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 7:07 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 910 | $41.17 | 13,547 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 7:08 pm | N/A N/A | Royalty Pharma plc | RPRX | Engelbert Catherine M. Director | 910 | $41.17 | 13,410 (Direct) | View |
| 2020-09-30 Option Award | 2020-10-02 7:09 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 613 | $41.17 | 7,893 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 9:48 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 463,200 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 9:48 pm | N/A N/A | Royalty Pharma plc | RPRX | RIGGS RORY B Director | 46,320 | $0 | 0 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-04 8:02 pm | N/A N/A | Royalty Pharma plc | RPRX | Bassler Bonnie L Director | 820 | $45.69 | 14,367 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-04 8:04 pm | N/A N/A | Royalty Pharma plc | RPRX | Fernandez Henry A Director | 820 | $45.69 | 8,713 (Direct) | View |
| 2020-12-31 Conversion | 2021-01-05 9:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 100,000 | $0 | 556,707 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 400,000 | $0 | 556,707 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 10,000 | $0 | 556,707 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. VP | 40,000 | $0 | 556,707 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 270,100 | $0 | 618,478 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 129,900 | $0 | 618,478 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 27,010 | $0 | 618,478 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. VP | 12,990 | $0 | 618,478 (Indirect) | View |
| 2020-06-18 Conversion | 2021-01-05 9:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 24,170 | $0 | 188 (Indirect) | View |
| 2020-06-18 Option Award | 2021-01-05 9:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 2,605 | $0 | 188 (Indirect) | View |
| 2020-06-18 Conversion | 2021-01-05 9:51 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 2,417 | $0 | 188 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:53 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 99,770 | $0 | 376,468 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:53 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 300,230 | $0 | 376,468 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:53 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 9,977 | $0 | 376,468 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:53 pm | N/A N/A | Royalty Pharma plc | RPRX | Coyne Terrance P. CFO | 30,023 | $0 | 376,468 (Indirect) | View |